Page last updated: 2024-11-08

puromycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID439530
CHEMBL ID469912
CHEBI ID17939
SCHEMBL ID4570
MeSH IDM0018173

Synonyms (80)

Synonym
puromicina [inn-spanish]
6-dimethylamino-9-(3'-(p-methoxy-l-phenylalanylamino)-beta-d-ribofuranosyl)-purine
stillomycin
puromycine [inn-french]
achromycin (purine derivative)
puromycin [usan:inn:ban]
3123l
adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-n,n-dimethyl-, (s)-
puromycinum [inn-latin]
cl-13900
adenosine, 3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-n,n-dimethyl-, l-
nsc 3055
BRD-K36007650-300-02-3
3123-l
CHEMBL469912
gnf-pf-2016 ,
puromicina
3'-deoxy-n,n-dimethyl-3'-(o-methyl-l-tyrosinamido)adenosine
3'-(l-alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-n,n-dimethyladenosine
3'-[[(2s)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-n,n-diemthyladenosine
(s)-3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-n,n-dimethyladenosine
puromycine
puromycinum
CHEBI:17939 ,
9-{3-deoxy-3-[(o-methyl-l-tyrosyl)amino]-beta-d-xylofuranosyl}-n,n-dimethyl-9h-purin-6-amine
cl 16536
nsc-3055
NCGC00179500-01
puromycin (usan)
D05653
PRESTWICK3_000480
BSPBIO_000620
BPBIO1_000682
(2s)-2-amino-n-[(2s,3s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]-3-(4-methoxyphenyl)propanamide
stylomycin
cl 13,900
adenosine, 3'-(-amino-p-methoxyhydrocinnamamido)-3'-deoxy-n, n-dimethyl-, dihydrochloride, l-
cl 16,536 (*dihydrochloride*)
p-638
AB00514661
53-79-2
C01610
puromycin ,
PUY ,
p 638
cl 13900
3'-deoxy-n,n-dimethyl-3'-[(o-methyl-l-tyrosyl)amino]adenosine
HMS2089F18
DB08437
TCMDC-123493 ,
(2s)-2-amino-n-[(2s,3s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
4a6zs6q2cl ,
adenosine, 3'-(((2s)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-n,n-dimethyl-
unii-4a6zs6q2cl
EPITOPE ID:140945
adenosine, 3'-[[(2s)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-n,n-dimethyl-
puromycin [mi]
puromycin [who-dd]
3'-(l-.alpha.-amino-p-methoxyhydrocinnamamido)-3'-deoxy-n,n-dimethyladenosine
puromycin [usan]
puromycin [inn]
RXWNCPJZOCPEPQ-NVWDDTSBSA-N
CCG-208505
BRD-K36007650-001-01-9
SCHEMBL4570
AB00514661-07
DTXSID8036788
puromycin, 10 mg/ml in distilled water
mfcd00866328
AKOS030485964
(s)-3'-[[2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-n,n-dimethyladenosine
CS-6500
HY-B1743
NCGC00179500-07
Q424696
Q27167243
2-amino-n-[5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
(s)-2-amino-n-((2s,3s,4r,5r)-5-(6-(dimethylamino)-9h-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)-3-(4-methoxyphenyl)propanamide
bdbm50277158
NCGC00179500-14

Research Excerpts

Overview

Puromycin is a tyrosyl-tRNA mimic that blocks translation by labeling and releasing elongating polypeptide chains from translating ribosomes. Puromycin technology is a useful tool for the detection of proteins and analysis of protein-protein interactions (PPIs)

ExcerptReferenceRelevance
"Puromycin is an antibiotic that mimics the 3'-terminal end of aminoacylated tRNAs and attaches to the carboxyl terminus of growing protein chains."( New selectable marker for manipulating the simple genomes of Mycoplasma species.
Algire, MA; Assad-Garcia, N; Glass, JI; Lartigue, C; Merryman, C; Thomas, DW, 2009
)
1.07
"Puromycin is an amino-acyl transfer RNA analog widely employed in studies of protein synthesis. "( Elongation inhibitors do not prevent the release of puromycylated nascent polypeptide chains from ribosomes.
Gonzalez, RL; Hartwick, EW; Hobson, BD; Kong, L; Sims, PA, 2020
)
2
"Puromycin is a tyrosyl-tRNA mimic that blocks translation by labeling and releasing elongating polypeptide chains from translating ribosomes. "( Puromycin reactivity does not accurately localize translation at the subcellular level.
Cassani, M; Enam, SU; Goldman, DH; Green, R; Livingston, NM; Seydoux, G; Zinshteyn, B, 2020
)
3.44
"Puromycin is a peptidyl transfer inhibitor, widely used in cell biology for tagging newly synthesized proteins."( A New Photocaged Puromycin for an Efficient Labeling of Newly Translated Proteins in Living Neurons.
Elamri, I; Herzig, LM; Heumüller, M; Schuman, EM; Schwalbe, H; Stirnal, E; Wachtveitl, J, 2018
)
1.54
"Puromycin technology is a useful tool for the detection of proteins and analysis of protein-protein interactions (PPIs); however, problems arise due to the existence of stop codons in the native mRNAs."( Efficiency of puromycin-based technologies mediated by release factors and a ribosome recycling factor.
Hirai, N; Ishizaka, M; Miyamoto-Sato, E; Ohashi, H, 2013
)
1.47
"Puromycin is an aminonucleoside antibiotic with structural similarity to aminoacyl tRNA. "( Identification and characterization of a drug-sensitive strain enables puromycin-based translational assays in Saccharomyces cerevisiae.
Cary, GA; Dudley, AM; Goodlett, DR; Hays, M; Ludlow, C; Torres, CG; Wang, K; Yoon, SH, 2014
)
2.08
"Puromycin is a peptidyl nucleoside endowed with significant antibiotic and anticancer properties, but also with an unfortunate nephrotoxic character that has hampered its use as a chemotherapeutic agent. "( Synthesis, stereochemical characterization, and antimicrobial evaluation of a potentially nonnephrotoxic 3'-C-acethydrazide puromycin analog.
Carter, J; Chiacchio, MA; Feske, BD; Gumina, G; Lynch, WE; Messersmith, AR; Weaver, BA, 2017
)
2.1
"Puromycin is a well-known antibiotic that inhibits protein synthesis by competitive incorporation against an aminoacyl tRNA on the ribosome A site. "( Next-generation protein-handling method: puromycin analogue technology.
Tabuchi, I, 2003
)
2.03
"Puromycin is an experimental anti-tumor antibiotic acting through inhibition of protein synthesis. "( Melanin counter act puromycin-induced inhibition of collagen and DNA biosynthesis in human skin fibroblasts.
Buszman, E; Karna, E; Pałka, J; Surazyński, A; Wrześniok, D, 2005
)
2.09
"Puromycin is a translation inhibitor that is able to enter the ribosome during translation and form a stable covalent bond with the nascent protein."( Protein selection using mRNA display.
Keefe, AD, 2001
)
1.03
"Puromycin is a general inhibitor of aminopeptidases and bestatin is a more selective inhibitor of Leu-aminopeptidases and aminopeptidase B."( Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
Cohen, ML; Geary, LE; Wiley, KS, 1983
)
1.21
"Puromycin is a potent inhibitor of bacterial protein synthesis, but puromycin-producing Streptomyces alboniger KCC S-0309 is tolerant to the antibiotic in vivo. "( Mechanism of self-protection in a puromycin-producing micro-organism.
Nomi, R; Paik, SY; Sugiyama, M, 1985
)
1.99

Effects

Puromycin has an inhibitory effect that could be related to similar substrate recognition mechanisms by rRNA in the ribosome and by RNase P.

Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. It has no effect on binding of dihydrostreptomycin to 70-S monosomes, as measured by equilibrium dialysis.

ExcerptReferenceRelevance
"Puromycin has a differential and dose-dependent effect."( dCMP-aminohydrolase activity during early sea urchin development. An example of negative enzyme control during embryogenesis.
De Petrocellis, B; Maharajan, V; Pratibha, M, 1984
)
0.99
"Puromycin has been used in molecular biology research for decades as a translation inhibitor."( Puromycin reactivity does not accurately localize translation at the subcellular level.
Cassani, M; Enam, SU; Goldman, DH; Green, R; Livingston, NM; Seydoux, G; Zinshteyn, B, 2020
)
2.72
"Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. "( Measurement of protein synthesis: in vitro comparison of (68)Ga-DOTA-puromycin, [ (3)H]tyrosine, and 2-fluoro-[ (3)H]tyrosine.
Beckford Vera, DR; Eigner, S; Fellner, M; Henke, KE; Lebeda, O; Loktionova, NS; Melichar, F; Piel, M; Roß, TL; Rösch, F, 2013
)
2.07
"Puromycin has no effect on binding of dihydrostreptomycin to 70-S monosomes, as measured by equilibrium dialysis."( Role of ribosome recycling in uptake of dihydrostreptomycin by sensitive and resistant Escherichia coli.
Braun, CB; Hurwitz, C; Rosano, CL, 1981
)
0.98
"Puromycin has a differential and dose-dependent effect."( dCMP-aminohydrolase activity during early sea urchin development. An example of negative enzyme control during embryogenesis.
De Petrocellis, B; Maharajan, V; Pratibha, M, 1984
)
0.99
"the puromycin reaction, has been analyzed with regard to its applicability under tRNA saturation conditions."( Analysis of the puromycin reaction. The ribosomal exclusion principle for AcPhe-tRNA binding re-examined.
Geigenmüller, U; Hausner, TP; Nierhaus, KH, 1986
)
1.1
"Puromycin has no effect on chain growth until 60 min after addition of the compound, even though thymidine incorporation is more than 50% reduced within 15 min."( DNA replication: direction and rate of chain growth in mammalian cells.
Hand, R; Tamm, I, 1973
)
0.97
"Puromycin has been used to break the bond between the s-RNA and the polypeptide, and in the absence of further protein synthesis this technique exposes free s-RNA molecules on the ribosomes."( The ribosomal binding site for peptidyl-transfer-ribonucleic acid.
Cannon, M, 1967
)
0.97

Actions

Puromycin blocked the increase in intake of the imbalanced diet whether injected with the DLAA or 6 h later. Puromycin did not inhibit PFK 2.

ExcerptReferenceRelevance
"Puromycin blocked the increase in intake of the imbalanced diet whether injected with the DLAA or 6 h later."( Protein synthesis in the prepyriform cortex: effects on intake of an amino acid-imbalanced diet by Sprague-Dawley rats.
Beverly, JL; Gietzen, DW; Rogers, QR, 1991
)
1
"Puromycin did not inhibit PFK 2."( Stimulation by insulin of glycolysis in cultured hepatocytes is attenuated by extracellular ATP and puromycin through purine-dependent inhibition of phosphofructokinase 2 activation.
Probst, I; Quentmeier, A; Schweickhardt, C; Unthan-Fechner, K, 1989
)
1.21
"Puromycin can inhibit chloramphenicol binding completely."( Identification of the chloramphenicol-binding protein in Escherichia coli ribosomes by partial reconstitution.
Nierhaus, D; Nierhaus, KH, 1973
)
0.97

Treatment

Puromycin treatment resulted in a cicatrix with initial decreased cell density but which contained a new class of nerve fibres at 30 DPO. Puromyc inhibited protein synthesis, but did not affect dolichol transfer from the endoplasmic reticulum to lysosomes.

ExcerptReferenceRelevance
"Puromycin-treated mice kidneys demonstrated a clearly reduced reactivity to the nephrin antibodies."( Hypercholesterolemia is a prerequisite for puromycin inducible damage in mouse kidney.
Aalto-Setälä, K; Cheng, ZZ; Holthöfer, H; Novikov, D; Pätäri, A; Schlöndorff, D, 2003
)
1.3
"Puromycin treatment of the biotinylvalyl-tRNA1(Val) -70S complex followed by irradiation, results in the appearance of the unusual photoproduct, which indicates an immediate change in the tRNA interaction with the ribosome after peptide transfer."( A 16S rRNA-tRNA product containing a nucleotide phototrimer and specific for tRNA in the P/E hybrid state in the Escherichia coli ribosome.
Huggins, W; Wollenzien, P, 2004
)
1.04
"Puromycin-treated SMCs showed signs of endoplasmic reticulum (ER) stress, as demonstrated by CCAAT/enhancer-binding protein homologous protein (CHOP) protein expression, splicing of X-box-binding protein 1 mRNA, and phosphorylation of eukaryotic translation initiation factor 2alpha."( Differential effect of the protein synthesis inhibitors puromycin and cycloheximide on vascular smooth muscle cell viability.
Croons, V; De Meyer, GR; Herman, AG; Martinet, W, 2008
)
1.31
"Puromycin treatment for 6 hr at 100 micrograms/ml almost completely, but reversibly, suppressed [35S]methionine incorporation into oocyte protein at all stages of maturation tested."( The induction of reversible and irreversible chromosome decondensation by protein synthesis inhibition during meiotic maturation of mouse oocytes.
Clarke, HJ; Masui, Y, 1983
)
0.99
"Puromycin and trypsin treatment failed to protect enkephalinamide from degradation over long periods of time (up to 24 hours)."( Degradation of enkephalin and enkephalinamide by neuroblastoma x glioma hybrid cells as studied by 13C n.m.r.
Deslauriers, R; Griffith, DW; Jarrell, HC; McGregor, WH; Smith, IC, 1980
)
0.98
"In puromycin-treated animals, mucosal lipid uptake was reduced and mucosal lipid content increased, particularly with oleic acid and in male rats."( [Puromycin action on intestinal lipid absorption in male and female rats].
Bernard, A; Carlier, H; Dutertre, A, 1980
)
1.69
"Puromycin pretreatment (10 mg ip) reduced total perfusate kallikrein from 105 +/- 19 to 8.5 +/- 3.6 (P < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)"( Kallikrein release by vascular tissue.
Carretero, OA; Nolly, H; Scicli, AG, 1993
)
1.01
"Puromycin treatment during incubation of oocytes within explanted oviducts produced a dose-dependent decrease in the percentage of oocyte exhibiting PVS staining after FITC-casein exposure."( Oviductal protein produces fluorescence staining of the perivitelline space in mouse oocytes.
Kim, H; Kim, MK; Kim, SR; Schuetz, AW, 1996
)
1.02
"Puromycin-treated apolipoprotein E (ApoE)-deficient mice were used to study lipid peroxidation (LPO) in the cochlea. "( Puromycin-induced lipid peroxidation in the cochlea of ApoE knockout mice.
Aalto-Setälä, K; Aarnisalo, AA; Holthöfer, H; Ylikoski, J, 2000
)
3.19
"Puromycin treatment induces transcription from all three HspR-dependent promoters, indicating that different environmental stresses are intracellularly sensed by the regulatory machinery through the accumulation of nonnative proteins."( Characterization of the HspR-mediated stress response in Helicobacter pylori.
Delany, I; Rappuoli, R; Scarlato, V; Spohn, G, 2002
)
1.04
"In puromycin-treated cells a small amount of pre-rRNA is synthesized but not processed into cytoplasmic rRNAs."( Effect of puromycin on synthesis, processing, and nucleocytoplasmic translocation of rRNA in Tetrahymena pyriformis.
Eckert, WA, 1977
)
1.17
"Puromycin treatment of lymphocytes was used to develop a one-way test for leukocyte migration inhibitory factor (LMIF) production in the mixed lymphocyte culture (MLC) reaction. "( Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.
Dupont, B; Good, RA; Górski, AJ; Hansen, JA, 1976
)
1.7
"Puromycin treatment detached more than 50% of the radioactivity from the polysomes; treatment of polysomes at pH 10.0 also caused the release of radioactivity."( Site of initial glycosylation of mannoproteins from Saccharomyces cerevisiae.
Ruiz-Herrera, J; Sentandreu, R, 1975
)
0.98
"Puromycin treatment resulted in a cicatrix with initial decreased cell density but which contained a new class of nerve fibres at 30 DPO."( Effect of puromycin treatment on the regeneration of hemisected and transected rat spinal cord.
Bernstein, JJ; Bernstein, ME; Wells, MR, 1978
)
1.38
"Puromycin treatment of Blas cells induced accumulation of monosomes and ribosomal subunits, while little if any transition of polyribosomes into monosome and ribosomal subunits appeared in its counterpart N742 treated with the same dose of puromycin."( The cross-resistance of mouse blasticidin S-resistant cell lines to puromycin and sparsomycin, inhibitors of ribosome function.
Kuwano, M; Ono, M; Takenaka, K, 1979
)
1.22
"Puromycin treatment decreased the uptake of glycine, L-proline, and alpha-aminoisobutyric acid but was without effect on the active uptake of all other amino acids tested."( Puromycin effect on amino acid transport: differential rates of carrier protein turnover.
Fisher, L; Granger, A; Phang, JM; Valle, DL, 1975
)
2.42
"Puromycin treatment released the 7S RNA from the polysomes, indicating that it is transiently associated with protein translation."( Association of the halobacterial 7S RNA to the polysome correlates with expression of the membrane protein bacterioopsin.
Betlach, MC; Gropp, F; Gropp, R, 1992
)
1
"Puromycin treatment inhibited protein synthesis, but did not affect dolichol transfer from the endoplasmic reticulum to lysosomes, suggesting that the transfer is not mediated by newly synthesized apoprotein."( Nonmembrane associated dolichol in rat liver.
Appelkvist, EL; Brunk, U; Edlund, C; Löw, P; Peterson, E, 1992
)
1
"Puromycin treatment results in inhibition of various proteins synthesized by type II epithelial cells."( Ultrastructural alterations of pulmonary surfactant in rat lungs after inhibition of protein synthesis by puromycin.
Celary-Walska, R; Groniowski, J; Groniowski, M; Walski, M, 1991
)
1.22
"puromycin-treated crabs indicates that puromycin totally blocks labeling of the new endocuticle with 3H glucosamine."( Concurrent protein synthesis is required for in vivo chitin synthesis in postmolt blue crabs.
Horst, MN, 1990
)
1
"Puromycin treatment causes the absorptive cell to accumulate increased quantities of lipid that are devoid of membrane during fat absorption."( Effects of puromycin on the structure of rat intestinal epithelial cells during fat absorption.
Cardell, RR; Friedman, HI, 1972
)
1.36
"Puromycin treatment of lac(+) strains mimics the effect of polar chain-termination mutations in destabilizing lac mRNA."( New polarity suppressors in Escherichia coli: suppression and messenger RNA stability.
Carter, T; Newton, A, 1971
)
0.97
"Treatment with puromycin of living cells or of isolated membrane fractions under a variety of ionic conditions revealed that the viral RNA-membrane linkage is insensitive to puromycin but sensitive to high concentrations of monovalent ions."( Studies on the intracellular distribution of Sindbis messenger RNA in infected chick-embryo fibroblasts. 1. Presence of extrapolyribosomal 26-S RNA in the membrane fraction.
Bonatti, S; Borgese, N; Cancedda, R; Cerasuolo, A; Meldolesi, J, 1980
)
0.6
"Pretreatment with puromycin (3 and 10 micrograms/ml), an inhibitor of protein synthesis, or actinomycin D (0.1-1 microgram/ml), an inhibitor of DNA-dependent RNA synthesis, also inhibited the antigen-induced histamine release in a concentration-dependent manner."( Inhibition of histamine release from RBL-2H3 cells by protein synthesis inhibitors.
Hirasawa, N; Katoh, M; Kawamura, R; Matsui, N; Mue, S; Ohuchi, K; Watanabe, M; Yomogida, S, 1994
)
0.61
"Treatment with puromycin reduced the percentage of GH or PRL secretors (plaque formers) by about half."( Relative importance of newly synthesized and stored hormone to basal secretion by growth hormone and prolactin cells.
Betts, JG; Chen, TT; Frawley, LS; Hill, JB; Kineman, RD, 1989
)
0.62
"Treatment with puromycin, an antibiotic which depresses incorporation into cytoplasmic proteins to a greater extent than into nuclear proteins, led to a situation in which the specific activities of the nuclear enzymes were several times as high as those of the corresponding cytoplasmic enzymes following a short period of incorporation."( Studies on the site of synthesis of several soluble enzymes of the cell nucleus.
Kuehl, L; Sumsion, EN, 1971
)
0.59

Toxicity

ExcerptReferenceRelevance
" Since the erythrocyte does not synthesize protein, the data indicate that puromycin has a direct toxic effect on erythroid cell membranes which is unrelated to its action in inhibiting the synthesis of protein."( Toxic effect of puromycin on erythrocyte membranes which is unrelated to inhibition of protein synthesis.
Ballas, SK; Burka, ER; Sabesin, SM, 1975
)
0.83
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems."( Developing structure-activity relationships for the prediction of hepatotoxicity.
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010
)
0.36
" This protocol describes a universal and efficient transgene targeted addition platform in human iPSCs based on utilization of validated open-source TALENs and a gene-trap-like donor to deliver transgenes into a safe harbor locus."( Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor.
Cerbini, T; Luo, Y; Rao, MS; Zou, J, 2015
)
0.42
" The treatment group received a toxic dose once daily of each investigated drug for 1 week."( Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents.
Cho, YS; Kim, DH; Long, NP; Oh, JH; Park, SM; Phat, NK; Shin, JG; Thu, VTA; Yen, NTH; Yoon, S, 2022
)
0.72
" The present results will contribute to the establishment of a safe and useful replicon system for analyzing SARS-CoV-2 replication mechanisms as well as the development of novel antiviral drugs in BSL-2 facilities."( Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
Kameoka, M; Kotaki, T; Nakamura, S; Takazawa, S; Utsubo, C, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
" Lastly, doses of proteasome inhibitors that are inadequate to block the activity of the proteasomes, caused cell death when combined with mifepristone; this phenotype was accompanied by accumulation of poly-ubiquitinated proteins denoting proteasome inhibition."( Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors.
Callegari, EA; Chien, J; Drappeau, DD; Eyster, KM; Gamarra-Luques, CD; Goyeneche, AA; Hapon, MB; Knapp, JR; Pan, B; Srinivasan, R; Telleria, CM; Terpstra, EJ; Wang, X; Zhang, L, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
"Aminopeptidase inhibitors may be useful for improving the systemic bioavailability of peptide drugs administered nasally or by other routes."( Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
Aungst, BJ; Hussain, MA; Koval, CA; Shenvi, AB, 1990
)
0.28
" However, the absorption rate showed a pattern consistent with saturable transport at high cholesterol concentrations in all groups."( Intestinal absorption and biliary secretion of cholesterol in rats with nephrotic syndrome.
Khamiseh, G; Oveisi, F; Pahl, MV; Vaziri, ND, 1998
)
0.3
" The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 milligrams/kilogram) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity."( Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y, 2011
)
0.37
" Indeed, several studies have implicated this bioavailability trait as a major road-block to resveratrol's potential clinical applications."( Toward Resolving the Resveratrol Conundrum: Synthesis and
Adsool, VA; Cui, YT; Goh, YL; Pendharkar, V, 2017
)
0.46
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The maximal values of both phases of secretion in the dose-response curve elicited by different glucose concentrations shift to the left when glibenclamide is added to the perfusate."( Studies on the dynamics and mechanism of glibenclamide-induced insulin secretion.
Basabe, JC; Chieri, RA; Farina, JM, 1976
)
0.26
" Dose-response relationships have been obtained for the attenuation of puromycin-induced amnesia in mice by selected neurohypophyseal peptides."( Dose-response relationships in attenuation of puromycin-induced amnesia by neurohypophyseal peptides.
Flexner, JB; Flexner, LB; Hoffman, PL; Walter, R, 1977
)
0.75
" The dose-response curves of the steroids differed, however, in that cyproterone acetate produced a greater mean stimulation of the enzyme at concentrations less than approximately 25 muM, whereas, at higher concentrations, cyproterone was the more effective inducer."( Cyproterone-mediated stimulation of delta-aminolevulinic acid synthetase in chick embryo liver cells.
Gidari, AS; Lane, SE; Levere, RD, 1976
)
0.26
" Injection of protein or glycoprotein precursors into one Rc produced heavy labeling of both Rcs including their processes; a slight labeling of other ganglion compartments was only found after increasing the dosage of the amino acids glycine and leucine."( Transfer of radioactive material between electrically coupled neurons of the leech central nervous system.
Kreutzberg, GW; Rieske, E; Schubert, P, 1975
)
0.25
" A dose-response activation of ODC was observed with saponin at concentrations between 2 and 10 micrograms/ml."( Saponin effects of prolactin-like stimulation of ornithine decarboxylase activity in mouse mammary gland explants.
Koduri, PB; Rillema, JA, 1992
)
0.28
" Dose-response experiments revealed a close correlation between the extent of protein synthesis inhibition and the level of activation of pp70-S6 kinase activity."( Distinct mechanisms for the activation of the RSK kinases/MAP2 kinase/pp90rsk and pp70-S6 kinase signaling systems are indicated by inhibition of protein synthesis.
Alcorta, DA; Blenis, J; Chung, J; Erikson, E; Erikson, RL, 1991
)
0.28
" Dose-response curves with ACTH showed that the hormone was effective in stimulating protein kinase C at lower concentrations than those required to increase steroid synthesis."( Protein kinase C in adrenal cells: possible role in regulation of steroid synthesis.
Hall, PF; Widmaier, EP, 1985
)
0.27
" In addition, the induction by low dosage of beta-ME requires de novo protein synthesis and is preceded by a drop in the rate of protein glycosylation."( Regulation of the glucose-regulated protein genes by beta-mercaptoethanol requires de novo protein synthesis and correlates with inhibition of protein glycosylation.
Kim, KS; Kim, YK; Lee, AS, 1987
)
0.27
" A dose-response assay of monocyte pyrogen in rabbits indicated a linear relationship of temperature elevation to dose of pyrogen at lower doses."( Studies on the mechanism of endogenous pyrogen production. III. Human blood monocytes.
Bodel, P, 1974
)
0.25
" These changes in phosphorylation were also observed in adrenal quarters and correlated well with ACTH-stimulated steroidogenesis as determined by temporal analysis and dose-response studies of corticosterone production."( The phosphorylation of adrenal proteins in response to adrenocorticotropic hormone.
Gallant, S; Koroscil, TM, 1981
)
0.26
" In dose-response studies, the contents of these phospholipids and pyruvate dehydrogenase activity increased in parallel in response to increasing concentrations of insulin."( The mechanism of action of insulin on phospholipid metabolism in rat adipose tissue. Requirement for protein synthesis and a carbohydrate source, and relationship to activation of pyruvate dehydrogenase.
Barnes, D; Farese, RV; Larson, RE; Sabir, MA; Trudeau, WL, 1984
)
0.27
" However, ketone bodies were consistently present in urine and several lethalities occurred during multiple dosing of captopril in SHR."( Effect of captopril on pre-existing and aminonucleoside-induced proteinuria in spontaneously hypertensive rats.
Brown, AD; Chiu, PJ, 1981
)
0.26
" Each of the biologically active catecholamines inhibited the measured enzyme activity, and dose-response curves indicated that dopamine was most effective and epinephrine least effective."( Inhibition of the enzymatic degradation of Met-enkephalin by catecholamines.
Caffrey, JL; Hodges, DH, 1982
)
0.26
" When male adult rats received d-limonene by gavage (0-300 mg/kg/day) for 14 consecutive days, dose-dependent increases in urinary excretion of alpha G-K were observed at a dosage level of more than 30 mg/kg/day."( Alpha 2u-globulins in the urine of male rats: a reliable indicator for alpha 2u-globulin accumulation in the kidney.
Kaneko, H; Nakatsuka, I; Saito, K; Shiba, K; Tomigahara, Y; Uwagawa, S, 1996
)
0.29
" Dose-response analysis showed that, in A549 cells, anisomycin strongly induced uPAR and PAI-1 mRNA at concentrations that did not cause complete inhibition of protein synthesis, whereas cycloheximide induced these transcripts in a dose-dependent manner only at concentrations sufficient to inhibit total protein synthesis by >90%."( Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund, LR, 1996
)
0.29
" The renal dysfunction induced by simultaneous administration of lisinopril with PAN could be abolished by combination dosing with sarcosine, an angiotensin II (AII)-receptor agonist."( Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
Kurihara, H; Shinosaki, T; Sunagawa, N; Takagawa, I; Yonetani, Y, 1997
)
0.59
" When the amount of EF-2 exceeded that of ribosomes sordarin inhibited the GTPase activity following an inverted bell-shaped dose-response curve, whereas when EF-2 and ribosomes were in equimolar concentrations sordarin yielded a typical sigmoidal dose-dependent inhibition."( Sordarin inhibits fungal protein synthesis by blocking translocation differently to fusidic acid.
Domínguez, JM; Gómez-Lorenzo, MG; Martín, JJ, 1999
)
0.3
" Dose-response experiments showed that precisely the same concentration of a specific drug was required to inhibit protein synthesis and to either stimulate or inhibit RNA replication."( Translating ribosomes inhibit poliovirus negative-strand RNA synthesis.
Barton, DJ; Flanegan, JB; Morasco, BJ, 1999
)
0.3
" Two different mechanisms were proposed for this phenotype: (i) classical mutation of drug metabolizing genes or (ii) chromosome reassortments, catalyzed by cancer- and cell line-specific aneuploidy, which generate, via new gene dosage combinations, a plethora of cancer phenotypes, including drug resistance."( Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.
Duesberg, P; Hehlmann, R; Stindl, R, 2001
)
0.31
" Since induction of ME activity by JH and JH analogs displayed a dose-response curve, specific for each tested component, we concluded that the hormonal action could be mediated through a receptor."( Regulation of cytosolic malate dehydrogenase by juvenile hormone in Drosophila melanogaster.
Danis, P; Farkas, R; Knopp, J; Mechler, BM; Medved'ová, L, 2002
)
0.31
" Han-Wistar rats were dosed with cisplatin [2."( Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury.
Cotter, M; De Ron, P; Dremier, S; Fleurance, R; Gryshkova, V; Nogueira da Costa, A; Obajdin, J; Snelling, S; Valentin, JP, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
nucleoside antibioticnull
antiinfective agentA substance used in the prophylaxis or therapy of infectious diseases.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
protein synthesis inhibitorA compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitorAn EC 3.4.11.* (aminopeptidase) inhibitor that interferes with the action of cytosol alanyl aminopeptidase (EC 3.4.11.14).
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitorAn EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitor that interferes with the action of dipeptidyl-peptidase II (EC 3.4.14.2).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
puromycins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (65)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency9.52210.01237.983543.2770AID1645841
GVesicular stomatitis virusPotency23.91850.01238.964839.8107AID1645842
Interferon betaHomo sapiens (human)Potency23.91850.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency23.91850.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency23.91850.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency23.91850.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
30S ribosomal protein S6Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S7Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L15Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L10Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L11Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L7/L12Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L19Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L1Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L20Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L27Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L28Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L29Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L31Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L31 type BEscherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L32Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L33Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L34Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L35Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L36Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S10Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S11Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S12Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S13Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S16Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S18Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S19Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S20Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S2Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S3Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S4Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S5Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S8Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S9Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L13Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L14Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L16Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L23Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S15Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L17Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L21Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L30Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L6Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S14Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S17Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S1Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L18Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
Aminopeptidase NHomo sapiens (human)IC50 (µMol)41.00000.40002.11003.9000AID1500912
Aminopeptidase NSus scrofa (pig)IC50 (µMol)100.00000.00053.53548.9000AID1264922
Puromycin-sensitive aminopeptidaseHomo sapiens (human)IC50 (µMol)6.07500.26003.97759.7000AID1264919; AID1500910
50S ribosomal protein L2Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L3Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L24Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L4Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L22Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L5Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
30S ribosomal protein S21Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L25Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
50S ribosomal protein L36 2Escherichia coli K-12IC50 (µMol)0.90000.00891.20355.0000AID531645
Tyrosyl-DNA phosphodiesterase 1Homo sapiens (human)IC50 (µMol)18,000.00000.01203.32138.4300AID1631085
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (93)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cytoplasmic translation30S ribosomal protein S6Escherichia coli K-12
translation30S ribosomal protein S6Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S7Escherichia coli K-12
negative regulation of translation30S ribosomal protein S7Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S7Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S7Escherichia coli K-12
translation30S ribosomal protein S7Escherichia coli K-12
negative regulation of translation30S ribosomal protein S7Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L15Escherichia coli K-12
translation50S ribosomal protein L15Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L10Escherichia coli K-12
translation50S ribosomal protein L10Escherichia coli K-12
regulation of translation50S ribosomal protein L10Escherichia coli K-12
negative regulation of translation50S ribosomal protein L10Escherichia coli K-12
translation50S ribosomal protein L11Escherichia coli K-12
translational termination50S ribosomal protein L11Escherichia coli K-12
stringent response50S ribosomal protein L11Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L11Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L11Escherichia coli K-12
translation50S ribosomal protein L11Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L7/L12Escherichia coli K-12
translation50S ribosomal protein L7/L12Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L19Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L19Escherichia coli K-12
translation50S ribosomal protein L19Escherichia coli K-12
negative regulation of translational initiation50S ribosomal protein L1Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L1Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L1Escherichia coli K-12
translation50S ribosomal protein L1Escherichia coli K-12
regulation of translation50S ribosomal protein L1Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L20Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L20Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L20Escherichia coli K-12
translation50S ribosomal protein L20Escherichia coli K-12
negative regulation of translation50S ribosomal protein L20Escherichia coli K-12
cytosolic ribosome assembly50S ribosomal protein L27Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L27Escherichia coli K-12
regulation of cell growth50S ribosomal protein L27Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L27Escherichia coli K-12
translation50S ribosomal protein L27Escherichia coli K-12
positive regulation of ribosome biogenesis50S ribosomal protein L27Escherichia coli K-12
assembly of large subunit precursor of preribosome50S ribosomal protein L27Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L28Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L28Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L28Escherichia coli K-12
translation50S ribosomal protein L28Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L29Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L29Escherichia coli K-12
translation50S ribosomal protein L29Escherichia coli K-12
translation50S ribosomal protein L31Escherichia coli K-12
translational initiation50S ribosomal protein L31Escherichia coli K-12
negative regulation of cytoplasmic translational initiation50S ribosomal protein L31Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L31Escherichia coli K-12
translation50S ribosomal protein L31Escherichia coli K-12
cellular response to zinc ion starvation50S ribosomal protein L31 type BEscherichia coli K-12
cytoplasmic translation50S ribosomal protein L31 type BEscherichia coli K-12
translation50S ribosomal protein L31 type BEscherichia coli K-12
response to reactive oxygen species50S ribosomal protein L32Escherichia coli K-12
response to radiation50S ribosomal protein L32Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L32Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L32Escherichia coli K-12
translation50S ribosomal protein L32Escherichia coli K-12
response to antibiotic50S ribosomal protein L33Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L33Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L33Escherichia coli K-12
translation50S ribosomal protein L33Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L34Escherichia coli K-12
translation50S ribosomal protein L34Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L35Escherichia coli K-12
translation50S ribosomal protein L35Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L36Escherichia coli K-12
translation50S ribosomal protein L36Escherichia coli K-12
transcription antitermination30S ribosomal protein S10Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S10Escherichia coli K-12
translation30S ribosomal protein S10Escherichia coli K-12
transcription antitermination30S ribosomal protein S10Escherichia coli K-12
regulation of DNA-templated transcription elongation30S ribosomal protein S10Escherichia coli K-12
ribosome biogenesis30S ribosomal protein S10Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S11Escherichia coli K-12
translation30S ribosomal protein S11Escherichia coli K-12
Group I intron splicing30S ribosomal protein S12Escherichia coli K-12
positive regulation of RNA splicing30S ribosomal protein S12Escherichia coli K-12
RNA folding30S ribosomal protein S12Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S12Escherichia coli K-12
translation30S ribosomal protein S12Escherichia coli K-12
response to antibiotic30S ribosomal protein S12Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S12Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S13Escherichia coli K-12
translation30S ribosomal protein S13Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S16Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S16Escherichia coli K-12
DNA metabolic process30S ribosomal protein S16Escherichia coli K-12
translation30S ribosomal protein S16Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S18Escherichia coli K-12
translation30S ribosomal protein S18Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S19Escherichia coli K-12
translation30S ribosomal protein S19Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S19Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S20Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S20Escherichia coli K-12
translation30S ribosomal protein S20Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S2Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S2Escherichia coli K-12
translation30S ribosomal protein S2Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S3Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S3Escherichia coli K-12
translation30S ribosomal protein S3Escherichia coli K-12
transcription antitermination30S ribosomal protein S4Escherichia coli K-12
negative regulation of translational initiation30S ribosomal protein S4Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S4Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S4Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S4Escherichia coli K-12
DNA-templated transcription termination30S ribosomal protein S4Escherichia coli K-12
translation30S ribosomal protein S4Escherichia coli K-12
regulation of translation30S ribosomal protein S4Escherichia coli K-12
transcription antitermination30S ribosomal protein S4Escherichia coli K-12
ribosome biogenesis30S ribosomal protein S4Escherichia coli K-12
response to antibiotic30S ribosomal protein S4Escherichia coli K-12
ribosomal small subunit biogenesis30S ribosomal protein S4Escherichia coli K-12
maintenance of translational fidelity30S ribosomal protein S5Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S5Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S5Escherichia coli K-12
translation30S ribosomal protein S5Escherichia coli K-12
response to antibiotic30S ribosomal protein S5Escherichia coli K-12
regulation of mRNA stability30S ribosomal protein S8Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S8Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S8Escherichia coli K-12
translation30S ribosomal protein S8Escherichia coli K-12
regulation of translation30S ribosomal protein S8Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S9Escherichia coli K-12
translation30S ribosomal protein S9Escherichia coli K-12
negative regulation of translation50S ribosomal protein L13Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L13Escherichia coli K-12
translation50S ribosomal protein L13Escherichia coli K-12
negative regulation of translation50S ribosomal protein L13Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L14Escherichia coli K-12
translation50S ribosomal protein L14Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L16Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L16Escherichia coli K-12
translation50S ribosomal protein L16Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L23Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L23Escherichia coli K-12
translation50S ribosomal protein L23Escherichia coli K-12
translation30S ribosomal protein S15Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S15Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S15Escherichia coli K-12
translation30S ribosomal protein S15Escherichia coli K-12
regulation of translation30S ribosomal protein S15Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L17Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L17Escherichia coli K-12
translation50S ribosomal protein L17Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L21Escherichia coli K-12
translation50S ribosomal protein L21Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L30Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L30Escherichia coli K-12
translation50S ribosomal protein L30Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L6Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L6Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L6Escherichia coli K-12
translation50S ribosomal protein L6Escherichia coli K-12
response to antibiotic50S ribosomal protein L6Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S14Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S14Escherichia coli K-12
translation30S ribosomal protein S14Escherichia coli K-12
response to antibiotic30S ribosomal protein S17Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S17Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S17Escherichia coli K-12
translation30S ribosomal protein S17Escherichia coli K-12
response to antibiotic30S ribosomal protein S17Escherichia coli K-12
translation30S ribosomal protein S1Escherichia coli K-12
RNA secondary structure unwinding30S ribosomal protein S1Escherichia coli K-12
negative regulation of cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
positive regulation of cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S1Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S1Escherichia coli K-12
translation30S ribosomal protein S1Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L18Escherichia coli K-12
translation50S ribosomal protein L18Escherichia coli K-12
angiogenesisAminopeptidase NHomo sapiens (human)
cell differentiationAminopeptidase NHomo sapiens (human)
symbiont entry into host cellAminopeptidase NHomo sapiens (human)
proteolysisAminopeptidase NHomo sapiens (human)
peptide catabolic processAminopeptidase NHomo sapiens (human)
protein polyubiquitinationPuromycin-sensitive aminopeptidaseHomo sapiens (human)
cellular response to hypoxiaPuromycin-sensitive aminopeptidaseHomo sapiens (human)
positive regulation of protein targeting to mitochondrionPuromycin-sensitive aminopeptidaseHomo sapiens (human)
peptide catabolic processPuromycin-sensitive aminopeptidaseHomo sapiens (human)
proteolysisPuromycin-sensitive aminopeptidaseHomo sapiens (human)
ribosomal large subunit assembly50S ribosomal protein L2Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L2Escherichia coli K-12
translation50S ribosomal protein L2Escherichia coli K-12
negative regulation of DNA-templated DNA replication initiation50S ribosomal protein L2Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L3Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L3Escherichia coli K-12
translation50S ribosomal protein L3Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L24Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L24Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L24Escherichia coli K-12
translation50S ribosomal protein L24Escherichia coli K-12
transcriptional attenuation50S ribosomal protein L4Escherichia coli K-12
negative regulation of cytoplasmic translation50S ribosomal protein L4Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L4Escherichia coli K-12
DNA-templated transcription termination50S ribosomal protein L4Escherichia coli K-12
translation50S ribosomal protein L4Escherichia coli K-12
regulation of translation50S ribosomal protein L4Escherichia coli K-12
negative regulation of translation50S ribosomal protein L4Escherichia coli K-12
ribosome assembly50S ribosomal protein L4Escherichia coli K-12
negative regulation of DNA-templated transcription50S ribosomal protein L4Escherichia coli K-12
response to antibiotic50S ribosomal protein L4Escherichia coli K-12
translation50S ribosomal protein L22Escherichia coli K-12
cytosolic ribosome assembly50S ribosomal protein L22Escherichia coli K-12
assembly of large subunit precursor of preribosome50S ribosomal protein L22Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L22Escherichia coli K-12
translation50S ribosomal protein L22Escherichia coli K-12
ribosome assembly50S ribosomal protein L22Escherichia coli K-12
response to antibiotic50S ribosomal protein L22Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L5Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L5Escherichia coli K-12
translation50S ribosomal protein L5Escherichia coli K-12
ribosomal small subunit assembly30S ribosomal protein S21Escherichia coli K-12
cytoplasmic translation30S ribosomal protein S21Escherichia coli K-12
translation30S ribosomal protein S21Escherichia coli K-12
translation50S ribosomal protein L25Escherichia coli K-12
response to radiation50S ribosomal protein L25Escherichia coli K-12
negative regulation of translation50S ribosomal protein L25Escherichia coli K-12
ribosomal large subunit assembly50S ribosomal protein L25Escherichia coli K-12
cytoplasmic translation50S ribosomal protein L25Escherichia coli K-12
translation50S ribosomal protein L25Escherichia coli K-12
translation50S ribosomal protein L36 2Escherichia coli K-12
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
single strand break repairTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
DNA repairTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
double-strand break repairTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (56)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
structural constituent of ribosome30S ribosomal protein S6Escherichia coli K-12
protein binding30S ribosomal protein S6Escherichia coli K-12
rRNA binding30S ribosomal protein S6Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S6Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S6Escherichia coli K-12
tRNA binding30S ribosomal protein S7Escherichia coli K-12
RNA binding30S ribosomal protein S7Escherichia coli K-12
mRNA binding30S ribosomal protein S7Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S7Escherichia coli K-12
protein binding30S ribosomal protein S7Escherichia coli K-12
rRNA binding30S ribosomal protein S7Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L15Escherichia coli K-12
protein binding50S ribosomal protein L15Escherichia coli K-12
rRNA binding50S ribosomal protein L15Escherichia coli K-12
GTPase activity50S ribosomal protein L10Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L10Escherichia coli K-12
protein binding50S ribosomal protein L10Escherichia coli K-12
rRNA binding50S ribosomal protein L10Escherichia coli K-12
ribosome binding50S ribosomal protein L10Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L10Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L11Escherichia coli K-12
protein binding50S ribosomal protein L11Escherichia coli K-12
rRNA binding50S ribosomal protein L11Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L11Escherichia coli K-12
GTPase activity50S ribosomal protein L7/L12Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L7/L12Escherichia coli K-12
protein binding50S ribosomal protein L7/L12Escherichia coli K-12
protein homodimerization activity50S ribosomal protein L7/L12Escherichia coli K-12
ribosome binding50S ribosomal protein L7/L12Escherichia coli K-12
mRNA binding50S ribosomal protein L7/L12Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L19Escherichia coli K-12
rRNA binding50S ribosomal protein L19Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L19Escherichia coli K-12
tRNA binding50S ribosomal protein L1Escherichia coli K-12
RNA binding50S ribosomal protein L1Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L1Escherichia coli K-12
protein binding50S ribosomal protein L1Escherichia coli K-12
rRNA binding50S ribosomal protein L1Escherichia coli K-12
mRNA regulatory element binding translation repressor activity50S ribosomal protein L20Escherichia coli K-12
mRNA binding50S ribosomal protein L20Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L20Escherichia coli K-12
rRNA binding50S ribosomal protein L20Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L20Escherichia coli K-12
tRNA binding50S ribosomal protein L27Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L27Escherichia coli K-12
protein binding50S ribosomal protein L27Escherichia coli K-12
rRNA binding50S ribosomal protein L27Escherichia coli K-12
ribosome binding50S ribosomal protein L27Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L28Escherichia coli K-12
protein binding50S ribosomal protein L28Escherichia coli K-12
rRNA binding50S ribosomal protein L28Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L29Escherichia coli K-12
rRNA binding50S ribosomal protein L29Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L31Escherichia coli K-12
zinc ion binding50S ribosomal protein L31Escherichia coli K-12
rRNA binding50S ribosomal protein L31Escherichia coli K-12
metal ion binding50S ribosomal protein L31Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L31 type BEscherichia coli K-12
structural constituent of ribosome50S ribosomal protein L32Escherichia coli K-12
protein binding50S ribosomal protein L32Escherichia coli K-12
tRNA binding50S ribosomal protein L33Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L33Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L34Escherichia coli K-12
protein binding50S ribosomal protein L34Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L35Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L36Escherichia coli K-12
tRNA binding30S ribosomal protein S10Escherichia coli K-12
transcription antitermination factor activity, RNA binding30S ribosomal protein S10Escherichia coli K-12
RNA binding30S ribosomal protein S10Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S10Escherichia coli K-12
protein binding30S ribosomal protein S10Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S11Escherichia coli K-12
protein binding30S ribosomal protein S11Escherichia coli K-12
rRNA binding30S ribosomal protein S11Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S11Escherichia coli K-12
tRNA binding30S ribosomal protein S12Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S12Escherichia coli K-12
protein binding30S ribosomal protein S12Escherichia coli K-12
rRNA binding30S ribosomal protein S12Escherichia coli K-12
misfolded RNA binding30S ribosomal protein S12Escherichia coli K-12
tRNA binding30S ribosomal protein S13Escherichia coli K-12
RNA binding30S ribosomal protein S13Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S13Escherichia coli K-12
protein binding30S ribosomal protein S13Escherichia coli K-12
rRNA binding30S ribosomal protein S13Escherichia coli K-12
four-way junction DNA binding30S ribosomal protein S16Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S16Escherichia coli K-12
endonuclease activity30S ribosomal protein S16Escherichia coli K-12
DNA endonuclease activity30S ribosomal protein S16Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S18Escherichia coli K-12
protein binding30S ribosomal protein S18Escherichia coli K-12
rRNA binding30S ribosomal protein S18Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S18Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S18Escherichia coli K-12
tRNA binding30S ribosomal protein S19Escherichia coli K-12
RNA binding30S ribosomal protein S19Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S19Escherichia coli K-12
rRNA binding30S ribosomal protein S19Escherichia coli K-12
RNA binding30S ribosomal protein S20Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S20Escherichia coli K-12
ornithine decarboxylase inhibitor activity30S ribosomal protein S20Escherichia coli K-12
rRNA binding30S ribosomal protein S20Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S20Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S2Escherichia coli K-12
protein binding30S ribosomal protein S2Escherichia coli K-12
zinc ion binding30S ribosomal protein S2Escherichia coli K-12
RNA binding30S ribosomal protein S3Escherichia coli K-12
mRNA binding30S ribosomal protein S3Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S3Escherichia coli K-12
rRNA binding30S ribosomal protein S3Escherichia coli K-12
mRNA regulatory element binding translation repressor activity30S ribosomal protein S4Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S4Escherichia coli K-12
protein binding30S ribosomal protein S4Escherichia coli K-12
rRNA binding30S ribosomal protein S4Escherichia coli K-12
mRNA 5'-UTR binding30S ribosomal protein S4Escherichia coli K-12
RNA binding30S ribosomal protein S5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S5Escherichia coli K-12
protein binding30S ribosomal protein S5Escherichia coli K-12
rRNA binding30S ribosomal protein S5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S8Escherichia coli K-12
rRNA binding30S ribosomal protein S8Escherichia coli K-12
tRNA binding30S ribosomal protein S9Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S9Escherichia coli K-12
RNA binding30S ribosomal protein S9Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L13Escherichia coli K-12
zinc ion binding50S ribosomal protein L13Escherichia coli K-12
mRNA 5'-UTR binding50S ribosomal protein L13Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L13Escherichia coli K-12
mRNA binding50S ribosomal protein L13Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L14Escherichia coli K-12
protein binding50S ribosomal protein L14Escherichia coli K-12
rRNA binding50S ribosomal protein L14Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L14Escherichia coli K-12
tRNA binding50S ribosomal protein L16Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L16Escherichia coli K-12
rRNA binding50S ribosomal protein L16Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L23Escherichia coli K-12
protein binding50S ribosomal protein L23Escherichia coli K-12
rRNA binding50S ribosomal protein L23Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S15Escherichia coli K-12
rRNA binding30S ribosomal protein S15Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S15Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L17Escherichia coli K-12
protein binding50S ribosomal protein L17Escherichia coli K-12
RNA binding50S ribosomal protein L21Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L21Escherichia coli K-12
rRNA binding50S ribosomal protein L21Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L30Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L6Escherichia coli K-12
rRNA binding50S ribosomal protein L6Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L6Escherichia coli K-12
tRNA binding30S ribosomal protein S14Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S14Escherichia coli K-12
rRNA binding30S ribosomal protein S14Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S17Escherichia coli K-12
zinc ion binding30S ribosomal protein S17Escherichia coli K-12
rRNA binding30S ribosomal protein S17Escherichia coli K-12
molecular adaptor activity30S ribosomal protein S17Escherichia coli K-12
small ribosomal subunit rRNA binding30S ribosomal protein S17Escherichia coli K-12
RNA binding30S ribosomal protein S1Escherichia coli K-12
single-stranded RNA binding30S ribosomal protein S1Escherichia coli K-12
mRNA binding30S ribosomal protein S1Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S1Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L18Escherichia coli K-12
5S rRNA binding50S ribosomal protein L18Escherichia coli K-12
rRNA binding50S ribosomal protein L18Escherichia coli K-12
virus receptor activityAminopeptidase NHomo sapiens (human)
aminopeptidase activityAminopeptidase NHomo sapiens (human)
metallopeptidase activityAminopeptidase NHomo sapiens (human)
signaling receptor activityAminopeptidase NHomo sapiens (human)
metalloaminopeptidase activityAminopeptidase NHomo sapiens (human)
zinc ion bindingAminopeptidase NHomo sapiens (human)
peptide bindingAminopeptidase NHomo sapiens (human)
aminopeptidase activityPuromycin-sensitive aminopeptidaseHomo sapiens (human)
zinc ion bindingPuromycin-sensitive aminopeptidaseHomo sapiens (human)
metalloaminopeptidase activityPuromycin-sensitive aminopeptidaseHomo sapiens (human)
peptide bindingPuromycin-sensitive aminopeptidaseHomo sapiens (human)
RNA binding50S ribosomal protein L2Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L2Escherichia coli K-12
protein binding50S ribosomal protein L2Escherichia coli K-12
zinc ion binding50S ribosomal protein L2Escherichia coli K-12
transferase activity50S ribosomal protein L2Escherichia coli K-12
rRNA binding50S ribosomal protein L2Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L3Escherichia coli K-12
protein binding50S ribosomal protein L3Escherichia coli K-12
rRNA binding50S ribosomal protein L3Escherichia coli K-12
RNA binding50S ribosomal protein L24Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L24Escherichia coli K-12
protein binding50S ribosomal protein L24Escherichia coli K-12
rRNA binding50S ribosomal protein L24Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L24Escherichia coli K-12
RNA-binding transcription regulator activity50S ribosomal protein L4Escherichia coli K-12
DNA binding50S ribosomal protein L4Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L4Escherichia coli K-12
protein binding50S ribosomal protein L4Escherichia coli K-12
rRNA binding50S ribosomal protein L4Escherichia coli K-12
translation repressor activity50S ribosomal protein L4Escherichia coli K-12
mRNA 5'-UTR binding50S ribosomal protein L4Escherichia coli K-12
endoribonuclease inhibitor activity50S ribosomal protein L4Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L22Escherichia coli K-12
protein binding50S ribosomal protein L22Escherichia coli K-12
rRNA binding50S ribosomal protein L22Escherichia coli K-12
large ribosomal subunit rRNA binding50S ribosomal protein L22Escherichia coli K-12
tRNA binding50S ribosomal protein L5Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L5Escherichia coli K-12
5S rRNA binding50S ribosomal protein L5Escherichia coli K-12
rRNA binding50S ribosomal protein L5Escherichia coli K-12
RNA binding50S ribosomal protein L5Escherichia coli K-12
structural constituent of ribosome30S ribosomal protein S21Escherichia coli K-12
rRNA binding30S ribosomal protein S21Escherichia coli K-12
RNA binding50S ribosomal protein L25Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L25Escherichia coli K-12
5S rRNA binding50S ribosomal protein L25Escherichia coli K-12
rRNA binding50S ribosomal protein L25Escherichia coli K-12
structural constituent of ribosome50S ribosomal protein L36 2Escherichia coli K-12
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
double-stranded DNA bindingTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
single-stranded DNA bindingTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
exonuclease activityTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
protein bindingTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
3'-tyrosyl-DNA phosphodiesterase activityTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (34)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cytoplasm30S ribosomal protein S6Escherichia coli K-12
cytosol30S ribosomal protein S6Escherichia coli K-12
ribosome30S ribosomal protein S6Escherichia coli K-12
intracellular organelle30S ribosomal protein S6Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S6Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S6Escherichia coli K-12
cytosol30S ribosomal protein S7Escherichia coli K-12
ribosome30S ribosomal protein S7Escherichia coli K-12
membrane30S ribosomal protein S7Escherichia coli K-12
cytoplasm30S ribosomal protein S7Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S7Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S7Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S7Escherichia coli K-12
ribosome30S ribosomal protein S7Escherichia coli K-12
ribosome50S ribosomal protein L15Escherichia coli K-12
cytoplasm50S ribosomal protein L15Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L15Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L15Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L15Escherichia coli K-12
cytosol50S ribosomal protein L10Escherichia coli K-12
ribosome50S ribosomal protein L10Escherichia coli K-12
cytoplasm50S ribosomal protein L10Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L10Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L10Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L10Escherichia coli K-12
cytosol50S ribosomal protein L11Escherichia coli K-12
ribosome50S ribosomal protein L11Escherichia coli K-12
cytoplasm50S ribosomal protein L11Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L11Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L11Escherichia coli K-12
cytoplasm50S ribosomal protein L7/L12Escherichia coli K-12
cytosol50S ribosomal protein L7/L12Escherichia coli K-12
ribosome50S ribosomal protein L7/L12Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L7/L12Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L7/L12Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L7/L12Escherichia coli K-12
cytosol50S ribosomal protein L19Escherichia coli K-12
ribosome50S ribosomal protein L19Escherichia coli K-12
cytoplasm50S ribosomal protein L19Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L19Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L19Escherichia coli K-12
cytosol50S ribosomal protein L1Escherichia coli K-12
ribosome50S ribosomal protein L1Escherichia coli K-12
cytoplasm50S ribosomal protein L1Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L1Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L1Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L1Escherichia coli K-12
cytosol50S ribosomal protein L20Escherichia coli K-12
ribosome50S ribosomal protein L20Escherichia coli K-12
cytoplasm50S ribosomal protein L20Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L20Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L20Escherichia coli K-12
ribosome50S ribosomal protein L27Escherichia coli K-12
cytoplasm50S ribosomal protein L27Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L27Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L27Escherichia coli K-12
cytosol50S ribosomal protein L28Escherichia coli K-12
ribosome50S ribosomal protein L28Escherichia coli K-12
cytoplasm50S ribosomal protein L28Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L28Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L28Escherichia coli K-12
ribosome50S ribosomal protein L29Escherichia coli K-12
cytoplasm50S ribosomal protein L29Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L29Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L29Escherichia coli K-12
cytosol50S ribosomal protein L31Escherichia coli K-12
ribosome50S ribosomal protein L31Escherichia coli K-12
cytoplasm50S ribosomal protein L31Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L31Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L31Escherichia coli K-12
ribosome50S ribosomal protein L31 type BEscherichia coli K-12
cytoplasm50S ribosomal protein L31 type BEscherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L31 type BEscherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L31 type BEscherichia coli K-12
cytosol50S ribosomal protein L32Escherichia coli K-12
ribosome50S ribosomal protein L32Escherichia coli K-12
cytoplasm50S ribosomal protein L32Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L32Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L32Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L32Escherichia coli K-12
cytoplasm50S ribosomal protein L33Escherichia coli K-12
cytosol50S ribosomal protein L33Escherichia coli K-12
ribosome50S ribosomal protein L33Escherichia coli K-12
intracellular organelle50S ribosomal protein L33Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L33Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L33Escherichia coli K-12
ribosome50S ribosomal protein L34Escherichia coli K-12
cytoplasm50S ribosomal protein L34Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L34Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L34Escherichia coli K-12
ribosome50S ribosomal protein L35Escherichia coli K-12
cytoplasm50S ribosomal protein L35Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L35Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L35Escherichia coli K-12
cytoplasm50S ribosomal protein L36Escherichia coli K-12
ribosome50S ribosomal protein L36Escherichia coli K-12
intracellular organelle50S ribosomal protein L36Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L36Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L36Escherichia coli K-12
cytosol30S ribosomal protein S10Escherichia coli K-12
ribosome30S ribosomal protein S10Escherichia coli K-12
cytoplasm30S ribosomal protein S10Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S10Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S10Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S10Escherichia coli K-12
cytosol30S ribosomal protein S11Escherichia coli K-12
ribosome30S ribosomal protein S11Escherichia coli K-12
cytoplasm30S ribosomal protein S11Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S11Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S11Escherichia coli K-12
cytosol30S ribosomal protein S12Escherichia coli K-12
ribosome30S ribosomal protein S12Escherichia coli K-12
cytoplasm30S ribosomal protein S12Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S12Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S12Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S12Escherichia coli K-12
ribosome30S ribosomal protein S12Escherichia coli K-12
cytosol30S ribosomal protein S13Escherichia coli K-12
ribosome30S ribosomal protein S13Escherichia coli K-12
cytoplasm30S ribosomal protein S13Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S13Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S13Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S13Escherichia coli K-12
cytosol30S ribosomal protein S13Escherichia coli K-12
cytoplasm30S ribosomal protein S16Escherichia coli K-12
ribosome30S ribosomal protein S16Escherichia coli K-12
intracellular organelle30S ribosomal protein S16Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S16Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S16Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S16Escherichia coli K-12
cytosol30S ribosomal protein S18Escherichia coli K-12
ribosome30S ribosomal protein S18Escherichia coli K-12
cytoplasm30S ribosomal protein S18Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S18Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S18Escherichia coli K-12
cytoplasm30S ribosomal protein S19Escherichia coli K-12
cytosol30S ribosomal protein S19Escherichia coli K-12
ribosome30S ribosomal protein S19Escherichia coli K-12
intracellular organelle30S ribosomal protein S19Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S19Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S19Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S19Escherichia coli K-12
cytosol30S ribosomal protein S20Escherichia coli K-12
ribosome30S ribosomal protein S20Escherichia coli K-12
cytoplasm30S ribosomal protein S20Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S20Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S20Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S20Escherichia coli K-12
cytosol30S ribosomal protein S20Escherichia coli K-12
ribosome30S ribosomal protein S2Escherichia coli K-12
cytoplasm30S ribosomal protein S2Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S2Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S2Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S2Escherichia coli K-12
cytosol30S ribosomal protein S3Escherichia coli K-12
ribosome30S ribosomal protein S3Escherichia coli K-12
cytoplasm30S ribosomal protein S3Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S3Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S3Escherichia coli K-12
cytosol30S ribosomal protein S4Escherichia coli K-12
ribosome30S ribosomal protein S4Escherichia coli K-12
cytoplasm30S ribosomal protein S4Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S4Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S4Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S4Escherichia coli K-12
cytoplasm30S ribosomal protein S5Escherichia coli K-12
cytosol30S ribosomal protein S5Escherichia coli K-12
ribosome30S ribosomal protein S5Escherichia coli K-12
intracellular organelle30S ribosomal protein S5Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S5Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S5Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S5Escherichia coli K-12
cytoplasm30S ribosomal protein S8Escherichia coli K-12
cytosol30S ribosomal protein S8Escherichia coli K-12
ribosome30S ribosomal protein S8Escherichia coli K-12
intracellular organelle30S ribosomal protein S8Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S8Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S8Escherichia coli K-12
cytosol30S ribosomal protein S9Escherichia coli K-12
ribosome30S ribosomal protein S9Escherichia coli K-12
intracellular organelle30S ribosomal protein S9Escherichia coli K-12
cytoplasm30S ribosomal protein S9Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S9Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S9Escherichia coli K-12
cytoplasm50S ribosomal protein L13Escherichia coli K-12
cytosol50S ribosomal protein L13Escherichia coli K-12
ribosome50S ribosomal protein L13Escherichia coli K-12
intracellular organelle50S ribosomal protein L13Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L13Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L13Escherichia coli K-12
ribosome50S ribosomal protein L13Escherichia coli K-12
cytosol50S ribosomal protein L14Escherichia coli K-12
ribosome50S ribosomal protein L14Escherichia coli K-12
cytoplasm50S ribosomal protein L14Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L14Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L14Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L14Escherichia coli K-12
ribosome50S ribosomal protein L16Escherichia coli K-12
cytoplasm50S ribosomal protein L16Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L16Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L16Escherichia coli K-12
ribosome50S ribosomal protein L23Escherichia coli K-12
cytoplasm50S ribosomal protein L23Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L23Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L23Escherichia coli K-12
cytoplasm30S ribosomal protein S15Escherichia coli K-12
cytosol30S ribosomal protein S15Escherichia coli K-12
ribosome30S ribosomal protein S15Escherichia coli K-12
intracellular organelle30S ribosomal protein S15Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S15Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S15Escherichia coli K-12
cytosol50S ribosomal protein L17Escherichia coli K-12
ribosome50S ribosomal protein L17Escherichia coli K-12
cytoplasm50S ribosomal protein L17Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L17Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L17Escherichia coli K-12
cytoplasm50S ribosomal protein L21Escherichia coli K-12
cytosol50S ribosomal protein L21Escherichia coli K-12
ribosome50S ribosomal protein L21Escherichia coli K-12
intracellular organelle50S ribosomal protein L21Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L21Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L21Escherichia coli K-12
ribosome50S ribosomal protein L30Escherichia coli K-12
cytoplasm50S ribosomal protein L30Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L30Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L30Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L30Escherichia coli K-12
cytosol50S ribosomal protein L6Escherichia coli K-12
ribosome50S ribosomal protein L6Escherichia coli K-12
cytoplasm50S ribosomal protein L6Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L6Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L6Escherichia coli K-12
cytoplasm30S ribosomal protein S14Escherichia coli K-12
ribosome30S ribosomal protein S14Escherichia coli K-12
intracellular organelle30S ribosomal protein S14Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S14Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S14Escherichia coli K-12
small ribosomal subunit30S ribosomal protein S14Escherichia coli K-12
ribosome30S ribosomal protein S17Escherichia coli K-12
cytoplasm30S ribosomal protein S17Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S17Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S17Escherichia coli K-12
cytoplasm30S ribosomal protein S1Escherichia coli K-12
ribosome30S ribosomal protein S1Escherichia coli K-12
membrane30S ribosomal protein S1Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S1Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S1Escherichia coli K-12
cytoplasm50S ribosomal protein L18Escherichia coli K-12
cytosol50S ribosomal protein L18Escherichia coli K-12
ribosome50S ribosomal protein L18Escherichia coli K-12
intracellular organelle50S ribosomal protein L18Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L18Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L18Escherichia coli K-12
extracellular spaceAminopeptidase NHomo sapiens (human)
lysosomal membraneAminopeptidase NHomo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentAminopeptidase NHomo sapiens (human)
plasma membraneAminopeptidase NHomo sapiens (human)
external side of plasma membraneAminopeptidase NHomo sapiens (human)
secretory granule membraneAminopeptidase NHomo sapiens (human)
extracellular exosomeAminopeptidase NHomo sapiens (human)
cytoplasmAminopeptidase NHomo sapiens (human)
plasma membraneAminopeptidase NHomo sapiens (human)
extracellular spaceAminopeptidase NHomo sapiens (human)
nucleusPuromycin-sensitive aminopeptidaseHomo sapiens (human)
cytosolPuromycin-sensitive aminopeptidaseHomo sapiens (human)
extracellular exosomePuromycin-sensitive aminopeptidaseHomo sapiens (human)
extracellular spacePuromycin-sensitive aminopeptidaseHomo sapiens (human)
cytoplasmPuromycin-sensitive aminopeptidaseHomo sapiens (human)
membranePuromycin-sensitive aminopeptidaseHomo sapiens (human)
cytosol50S ribosomal protein L2Escherichia coli K-12
ribosome50S ribosomal protein L2Escherichia coli K-12
cytoplasm50S ribosomal protein L2Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L2Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L2Escherichia coli K-12
DnaA-L2 complex50S ribosomal protein L2Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L2Escherichia coli K-12
cytosol50S ribosomal protein L3Escherichia coli K-12
ribosome50S ribosomal protein L3Escherichia coli K-12
cytoplasm50S ribosomal protein L3Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L3Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L3Escherichia coli K-12
cytosol50S ribosomal protein L24Escherichia coli K-12
ribosome50S ribosomal protein L24Escherichia coli K-12
cytoplasm50S ribosomal protein L24Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L24Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L24Escherichia coli K-12
cytosol50S ribosomal protein L4Escherichia coli K-12
ribosome50S ribosomal protein L4Escherichia coli K-12
cytoplasm50S ribosomal protein L4Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L4Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L4Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L4Escherichia coli K-12
cytosol50S ribosomal protein L22Escherichia coli K-12
ribosome50S ribosomal protein L22Escherichia coli K-12
cytoplasm50S ribosomal protein L22Escherichia coli K-12
large ribosomal subunit50S ribosomal protein L22Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L22Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L22Escherichia coli K-12
cytosol50S ribosomal protein L5Escherichia coli K-12
ribosome50S ribosomal protein L5Escherichia coli K-12
cytoplasm50S ribosomal protein L5Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L5Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L5Escherichia coli K-12
cytosol30S ribosomal protein S21Escherichia coli K-12
ribosome30S ribosomal protein S21Escherichia coli K-12
cytoplasm30S ribosomal protein S21Escherichia coli K-12
cytosolic small ribosomal subunit30S ribosomal protein S21Escherichia coli K-12
ribonucleoprotein complex30S ribosomal protein S21Escherichia coli K-12
cytosol50S ribosomal protein L25Escherichia coli K-12
ribosome50S ribosomal protein L25Escherichia coli K-12
cytoplasm50S ribosomal protein L25Escherichia coli K-12
cytosolic large ribosomal subunit50S ribosomal protein L25Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L25Escherichia coli K-12
ribosome50S ribosomal protein L36 2Escherichia coli K-12
cytosolic ribosome50S ribosomal protein L36 2Escherichia coli K-12
ribonucleoprotein complex50S ribosomal protein L36 2Escherichia coli K-12
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
cytoplasmTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
plasma membraneTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
intracellular membrane-bounded organelleTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
nucleusTyrosyl-DNA phosphodiesterase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (200)

Assay IDTitleYearJournalArticle
AID1504885Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID1241211Binding affinity to 5'-FAM-pre-miR-373 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID157092Ratio of kinetic parameter Vmax to that of Km in Rat liver ribosome1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID1355868Antiplasmodial activity against drug-sensitive Plasmodium falciparum 3D7 ring stage infected in human erythrocytes after 72 hrs by DAPI staining based method2018Journal of natural products, 07-27, Volume: 81, Issue:7
Antiplasmodial β-Triketone-Flavanone Hybrids from the Flowers of the Australian Tree Corymbia torelliana.
AID157084Substrate efficiency was evaluated by using peptidyl transferase assay against Escherichia coli ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1574649Growth inhibition of HEK293 cells at 40 uM after 72 hrs by resazurin dye based assay relative to control2019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
AID1500911Inhibition of recombinant human C-terminal His10-tagged APN (Lys69 to Lys967 residues) at 10 uM using Ala-AMC as substrate measured for 20 mins by fluorescence assay relative to control2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID683594Growth inhibition of human SU8686 cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID683592Growth inhibition of human PANC1 cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID319347Growth inhibition of human K562 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID1585774Antiparasitic activity against bloodstream form of Trypanosoma brucei brucei strain 427 after 48 hrs by resazurin dye-based assay2018Journal of medicinal chemistry, 12-27, Volume: 61, Issue:24
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity.
AID69587Kinetic constant was evaluated by using peptidyl transferase assay against Escherichia coli ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID1779233Antimalarial activity against synchronous ring stage of Plasmodium falciparum 3D7 assessed as parasite growth inhibition incubated for 72 hrs by Griffith assay based fluorescence analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
AID531645Displacement of [3H]puromycin from 70S ribosomal complex in Staphylococcus aureus ATCC 29213 by competitive binding assay2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
AID513822Increase in hybrid-state occupancy by tRNA in ribosomal pre-translocation complex in Escherichia coli MRE600 by smFRET method in presence of 10 uM neomycin2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID319349Resistant ratio, IC50 for multidrug resistant human K562 cells to IC50 for human K562 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID184435Kinetic constant was evaluated by using peptidyl transferase assay against Rat liver ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID681121TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID1462232Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by DAPI staining-based fluorescence microscopic analysis2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid.
AID1699651Cytotoxicity against human HEK293 cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay2020Journal of natural products, 11-25, Volume: 83, Issue:11
Antiplasmodial Alkaloids from the Australian Bryozoan
AID1437501Growth inhibition of HEK293 cells after 72 hrs by PrestoBlue staining based fluorescence assay
AID1274588Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of parasite growth after 72 hrs by DAPI staining-based confocal microscopic analysis2015Journal of natural products, Dec-24, Volume: 78, Issue:12
Rotenoids, Flavonoids, and Chalcones from the Root Bark of Millettia usaramensis.
AID1639284Antiplasmodial activity against drug-resistant Plasmodium falciparum Dd2 ring stage forms assessed as inhibition of parasite growth after 72 hrs by DAPI staining-based confocal microscopic analysis2019Journal of natural products, 04-26, Volume: 82, Issue:4
Acrotrione: An Oxidized Xanthene from the Roots of Acronychia pubescens.
AID1305448Antimalarial activity against Plasmodium falciparum 3D7 incubated for 72 hours by DAPI-staining based confocal imaging analysis2016Bioorganic & medicinal chemistry letters, 07-15, Volume: 26, Issue:14
Selective anti-malarial minor groove binders.
AID319341Growth inhibition of human KB3-1 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID449703NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay 2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID1699652Selectivity index, ratio of IC50 for cytotoxicity against human HEK293 cells to IC50 for antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 ring stage2020Journal of natural products, 11-25, Volume: 83, Issue:11
Antiplasmodial Alkaloids from the Australian Bryozoan
AID51924Effect on cross resistance of chinese hamster cells resistant to Actinomycin D.1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Structure-activity relationships of antineoplastic agents in multidrug resistance.
AID1699650Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 ring stage incubated for 72 hrs by DAPI-staining based imaging analysis2020Journal of natural products, 11-25, Volume: 83, Issue:11
Antiplasmodial Alkaloids from the Australian Bryozoan
AID683591Growth inhibition of human MDA-M cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID154295Percent inhibition of [75Se]- selenomethionine incorporation in the protein synthesis assay in P815 cell lines at a concentration of 10 E-3 M1983Journal of medicinal chemistry, Nov, Volume: 26, Issue:11
Synthesis and biological evaluation of sparsomycin analogues.
AID562801Antimicrobial activity against Mycoplasma capricolum harboring pMycoPuro plasmid encoding PAC gene at 300 ug/ml after 24 hrs2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID1695263Antitrypanosomal activity against Trypanosoma brucei brucei Lister 427 infected in human HEK293 cells assessed as parasite growth inhibition measured after 48 hrs by alamar blue assay
AID514833Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as increase in classical-state occupancy by tRNA by crystallography2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1430673Cytotoxicity against human MIAPaCa2 cells assessed as growth inhibition after 72 hrs by CellTitre-Glo luminescent assay2017ACS medicinal chemistry letters, May-11, Volume: 8, Issue:5
Toward Resolving the Resveratrol Conundrum: Synthesis and
AID157086Ratio of kinetic parameter Vmax to that of Km in Escherichia coli ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID1500914Cytotoxicity against African green monkey Vero cells assessed as reduction in cell proliferation after 72 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID1303013Cytotoxicity against human A549 cells2016European journal of medicinal chemistry, Jul-19, Volume: 117Design, synthesis and biological evaluation of diaziridinyl quinone isoxazole hybrids.
AID1699649Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 ring stage incubated for 72 hrs by DAPI-staining based imaging analysis2020Journal of natural products, 11-25, Volume: 83, Issue:11
Antiplasmodial Alkaloids from the Australian Bryozoan
AID1305454Therapeutic ratio of IC50 for HEK293 cells to IC50 for Plasmodium falciparum 3D72016Bioorganic & medicinal chemistry letters, 07-15, Volume: 26, Issue:14
Selective anti-malarial minor groove binders.
AID1779234Antimalarial activity against synchronous ring stage of Plasmodium falciparum Dd2 assessed as parasite growth inhibition incubated for 72 hrs by Griffith assay based fluorescence analysis2021European journal of medicinal chemistry, Oct-05, Volume: 221Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
AID319342Growth inhibition of human KB V1 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID23702Partition coefficient (logP)1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
AID1423596Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID774663Antimalarial activity against early (1 to 3) gametocytic stage of Plasmodium falciparum after 72 hrs by image-based HTS assay2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
Approaches to protozoan drug discovery: phenotypic screening.
AID683458Growth inhibition of human HEK293 cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID1437499Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in human RBC after 72 hrs by DAPI staining based confocal microscopic method
AID1638527Antimalarial activity against Plasmodium falciparum 3D7 infected HEK293 cells by DAPI-staining based assay2019Journal of medicinal chemistry, 03-14, Volume: 62, Issue:5
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
AID1404601Selectivity index, ratio of IC50 for HEK293 cells to IC50 for chloroquine-resistant Plasmodium falciparum Dd22018Journal of natural products, 04-27, Volume: 81, Issue:4
Microthecaline A, a Quinoline Serrulatane Alkaloid from the Roots of the Australian Desert Plant Eremophila microtheca.
AID562808Antimicrobial activity against Escherichia coli at 10 to 50 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID1264920Inhibition of Plasmodium falciparum aminopeptidase-N using Leu-pNA as substrate after 30 mins2015European journal of medicinal chemistry, Dec-01, Volume: 106Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
AID1132944Activity of Escherichia coli ribosomal peptidyl transferase using Ac[14C]phe-tRNA as donor substrate assessed as [14C]polyphenylalanine formation after 40 mins by double reciprocal plot analysis in presence of poly(U)1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Peptidyl transferase substrate specificity with nonaromatic aminoacyl analogues of puromycin.
AID1423593Antibacterial activity against Bacillus subtilis ATCC 6633 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID624623Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID69586Tested for the inhibitory activity against N-acetyl-L-phenylalanyl tRNA-70S Escherichia coli ribosome poly-U complex1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Sparsophenicol: a new synthetic hybrid antibiotic inhibiting ribosomal peptide synthesis.
AID1404593Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by DAPI staining based fluorescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Microthecaline A, a Quinoline Serrulatane Alkaloid from the Roots of the Australian Desert Plant Eremophila microtheca.
AID513821Increase in hybrid-state occupancy by tRNA in ribosomal pre-translocation complex in Escherichia coli MRE600 by smFRET method in presence of 20 uM neomycin2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID154167Percent inhibition of [75Se]- selenomethionine incorporation in the protein synthesis assay in P388 cell lines at a concentration of 10 E-3 M1983Journal of medicinal chemistry, Nov, Volume: 26, Issue:11
Synthesis and biological evaluation of sparsomycin analogues.
AID1181620Trypanocidal activity against Trypanosoma brucei brucei after 48 hrs by hemocytometry relative to control2014Journal of medicinal chemistry, Aug-14, Volume: 57, Issue:15
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
AID1241209Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID57470Inhibitory activity against dihydrofolate reductase (DHFR) isolated from murine L5178Y tumor cells resistant and sensitive to methotrexate1984Journal of medicinal chemistry, Mar, Volume: 27, Issue:3
Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
AID1404595Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by DAPI staining based fluorescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Microthecaline A, a Quinoline Serrulatane Alkaloid from the Roots of the Australian Desert Plant Eremophila microtheca.
AID319348Growth inhibition of doxorubicin-resistant human K562 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID1423600Antibacterial activity against Salmonella enterica ATCC 10708 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID157236Michaelis constant (Km) in the peptidyltransferase reaction1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Puromycin analogues. Effect of aryl-substituted puromycin analogues on the ribosomal peptidyltransferase reaction.
AID624626Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID1462233Selectivity ratio of IC50 for Plasmodium falciparum Dd2 to IC50 for Plasmodium falciparum 3D72017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid.
AID42637Percent inhibition of [75Se]- selenomethionine incorporation in the protein synthesis assay in bone marrow cell lines at a concentration of 10 E-31983Journal of medicinal chemistry, Nov, Volume: 26, Issue:11
Synthesis and biological evaluation of sparsomycin analogues.
AID1779235Selectivity index, ratio of IC50 for antimalarial activity against Plasmodium falciparum Dd2 to IC50 of antimalarial activity against Plasmodium falciparum 3D72021European journal of medicinal chemistry, Oct-05, Volume: 221Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID624622Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID1574648Growth inhibition of HEK293 cells at 10 uM after 72 hrs by resazurin dye based assay relative to control2019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
AID1450025Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 measured after 72 hrs by DAPI staining based high throughput screening assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
AID562802Antimicrobial activity against wild-type Mycoplasma capricolum at 3.7 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID514837Increase in classical-state occupancy by tRNA in ribosomal pre-translocation complex in Escherichia coli MRE600 by smFRET method in presence of 200 nM neomycin2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID157239Vmax in the peptidyltransferase reaction1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Puromycin analogues. Effect of aryl-substituted puromycin analogues on the ribosomal peptidyltransferase reaction.
AID683459Growth inhibition of human MCF10A cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID588209Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset2010Chemical research in toxicology, Jul-19, Volume: 23, Issue:7
Developing structure-activity relationships for the prediction of hepatotoxicity.
AID157087Kinetic constant was evaluated by using peptidyl transferase assay against Escherichia coli ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID683452Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasite replication incubated for 62 hrs2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID1181619Trypanocidal activity against Trypanosoma brucei brucei after 24 hrs by hemocytometry relative to control2014Journal of medicinal chemistry, Aug-14, Volume: 57, Issue:15
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
AID1574650Selectivity index, ratio of CC50 for HEK293 cells to IC50 for Plasmodium falciparum 3D72019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
AID1639288Selectivity index, ratio of IC50 for HEK293 cells to IC50 for drug-sensitive Plasmodium falciparum 3D7 ring stage forms2019Journal of natural products, 04-26, Volume: 82, Issue:4
Acrotrione: An Oxidized Xanthene from the Roots of Acronychia pubescens.
AID157088Substrate efficiency was evaluated by using peptidyl transferase assay against Rat liver ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID1404600Selectivity index, ratio of IC50 for HEK293 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D72018Journal of natural products, 04-27, Volume: 81, Issue:4
Microthecaline A, a Quinoline Serrulatane Alkaloid from the Roots of the Australian Desert Plant Eremophila microtheca.
AID23271Partition coefficient (logD7.4)1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Structure-activity relationships of antineoplastic agents in multidrug resistance.
AID562804Antimicrobial activity against wild-type Mycoplasma pneumoniae at 1 to 3 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID1504881Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by DAPI staining based confocal microplate imaging method2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID1430672Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by CellTitre-Glo luminescent assay2017ACS medicinal chemistry letters, May-11, Volume: 8, Issue:5
Toward Resolving the Resveratrol Conundrum: Synthesis and
AID1305450Antimalarial activity against Plasmodium falciparum Dd2 incubated for 72 hours by DAPI-staining based confocal imaging analysis2016Bioorganic & medicinal chemistry letters, 07-15, Volume: 26, Issue:14
Selective anti-malarial minor groove binders.
AID406181Growth inhibition of multidrug resistant human HepG2/Dox cells after 72 hrs by SRB assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells.
AID1462231Antimalarial activity against Plasmodium falciparum 3D7 after 72 hrs by DAPI staining-based fluorescence microscopic analysis2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid.
AID588210Human drug-induced liver injury (DILI) modelling dataset from Ekins et al2010Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 38, Issue:12
A predictive ligand-based Bayesian model for human drug-induced liver injury.
AID45400Effect on cross resistance of CHO cells resistant to colchicine (CHRC5)1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Structure-activity relationships of antineoplastic agents in multidrug resistance.
AID406328Growth inhibition of human HepG2 cells after 72 hrs by SRB assay2008Journal of natural products, Jun, Volume: 71, Issue:6
Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells.
AID1241207Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1437504Selectivity index, ratio of IC50 for HEK293 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7 infected in human RBC
AID1423595Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID1695260Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 48 hrs by resazurin assay
AID1648005Cytotoxicity against HEK293 cells2020Journal of natural products, 02-28, Volume: 83, Issue:2
A Meroisoprenoid, Heptenolides, and
AID1462240Selectivity index, ratio of IC50 for HEK293 cells to IC50 for Plasmodium falciparum 3D72017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid.
AID774661Antimalarial activity against late (4 to 5) gametocytic stage of Plasmodium falciparum after 72 hrs by image-based HTS assay2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
Approaches to protozoan drug discovery: phenotypic screening.
AID683593Growth inhibition of human BxPC3 cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID1574645Antimalarial activity against Plasmodium falciparum 3D7 after 72 hrs by DAPI staining-based confocal imaging analysis2019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
AID1274589Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 assessed as inhibition of parasite growth after 72 hrs by DAPI staining-based confocal microscopic analysis2015Journal of natural products, Dec-24, Volume: 78, Issue:12
Rotenoids, Flavonoids, and Chalcones from the Root Bark of Millettia usaramensis.
AID1631085Inhibition of human N-terminal His-tagged TDP1 expressed in Escherichia coli BL21 using [32P]-D14Y duplex DNA as substrate incubated for 20 mins by PAGE analysis2016Bioorganic & medicinal chemistry, 11-01, Volume: 24, Issue:21
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
AID1175721Antigametocytocidal activity against Plasmodium falciparum NF54-pfs16-GPF late (4 to 6) gametocyte assessed as viability after 72 hrs by MitoTracker Red CM-H2XRos/micro-plate confocal imaging system2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID1237997Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of parasite growth2015Bioorganic & medicinal chemistry, Aug-15, Volume: 23, Issue:16
From hybrid compounds to targeted drug delivery in antimalarial therapy.
AID1500916Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID277998Antifungal activity against Saccharomyces cerevisiae2007Journal of natural products, Feb, Volume: 70, Issue:2
Antimicrobial ambiguines from the cyanobacterium Fischerella sp. collected in Israel.
AID449706NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID1404378Antiparasitic activity against Cryptosporidium parvum SPL infected in human HCT8 cells incubated for 48 hrs by FITC/DAPI staining based fluorescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.
AID1679073Antitrypanosomal activity against Trypanosoma brucei brucei 427 assessed as parasite growth inhibition incubated for 48 hrs by resazurin dye based assay2020RSC medicinal chemistry, Dec-17, Volume: 11, Issue:12
Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness.
AID353131Inhibition of penicillin-resistant Streptococcus pneumoniae 159 recombinant MurM at 1 mM by liquid scintillation counting2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors.
AID1303014Cytotoxicity against human PC3 cells2016European journal of medicinal chemistry, Jul-19, Volume: 117Design, synthesis and biological evaluation of diaziridinyl quinone isoxazole hybrids.
AID1404381Cytotoxicity against human HEK293T cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo reagent based luminescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.
AID562806Antimicrobial activity against wild-type Mycoplasma genitalium at 1 to 3 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID319346Resistant ratio, IC50 for multidrug resistant human HepG2 cells to IC50 for human HepG2 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID1311942Binding affinity to MS2-tagged 50s rRNA A-site in Escherichia coli BL21(DE3) by single molecule FRET assay2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
The development of peptide ligands that target helix 69 rRNA of bacterial ribosomes.
AID1423599Antibacterial activity against Escherichia coli NRRL B-3708 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID489462Cytotoxicity against HEK239 cells after 72 hrs by Alamar blue assay2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
7',8'-Dihydroobolactone, a typanocidal alpha-pyrone from the rainforest tree Cryptocarya obovata.
AID774658Antimalarial activity against asexual stage of Plasmodium falciparum 3D7 after 72 hrs by image-based HTS assay2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
Approaches to protozoan drug discovery: phenotypic screening.
AID1462235Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay2017Bioorganic & medicinal chemistry letters, 09-01, Volume: 27, Issue:17
Synthesis of antimalarial amide analogues based on the plant serrulatane diterpenoid 3,7,8-trihydroxyserrulat-14-en-19-oic acid.
AID1679081Selectivity index, ratio of IC50 for human HEK293 cells to IC50 for antitrypanosomal activity against Trypanosoma brucei brucei 4272020RSC medicinal chemistry, Dec-17, Volume: 11, Issue:12
Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness.
AID157238Compound was evaluated for the irreversible inactivation of peptidyltransferase of Escherichia coli ribosomes.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Puromycin analogues. Effect of aryl-substituted puromycin analogues on the ribosomal peptidyltransferase reaction.
AID1404602Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by alamar blue assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Microthecaline A, a Quinoline Serrulatane Alkaloid from the Roots of the Australian Desert Plant Eremophila microtheca.
AID562807Antimicrobial activity against wild-type Mycoplasma mycoides at 1 to 3 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID1264919Inhibition of recombinant human puromycin sensitive aminopeptidase using Leu-pNA as substrate after 30 mins2015European journal of medicinal chemistry, Dec-01, Volume: 106Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
AID1241206Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1355872Cytotoxicity against human HEK293 cells after 72 hrs by resazurin dye based fluorescence assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Antiplasmodial β-Triketone-Flavanone Hybrids from the Flowers of the Australian Tree Corymbia torelliana.
AID1404379Cytotoxicity against human HCT8 cells2018Journal of natural products, 04-27, Volume: 81, Issue:4
Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.
AID1305451Cytotoxicity against HEK293 cells by alamar blue assay2016Bioorganic & medicinal chemistry letters, 07-15, Volume: 26, Issue:14
Selective anti-malarial minor groove binders.
AID1355869Antiplasmodial activity against 4-aminoquinoline/antifolates-resistant Plasmodium falciparum Dd2 ring stage infected in human erythrocytes after 72 hrs by DAPI staining based method2018Journal of natural products, 07-27, Volume: 81, Issue:7
Antiplasmodial β-Triketone-Flavanone Hybrids from the Flowers of the Australian Tree Corymbia torelliana.
AID1430674Cytotoxicity against human SU-DHL10 cells assessed as growth inhibition after 72 hrs by CellTitre-Glo luminescent assay2017ACS medicinal chemistry letters, May-11, Volume: 8, Issue:5
Toward Resolving the Resveratrol Conundrum: Synthesis and
AID1504889Selectivity index, ratio of IC50 for HEK293 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D72017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID1639283Antiplasmodial activity against drug-sensitive Plasmodium falciparum 3D7 ring stage forms assessed as inhibition of parasite growth after 72 hrs by DAPI staining-based confocal microscopic analysis2019Journal of natural products, 04-26, Volume: 82, Issue:4
Acrotrione: An Oxidized Xanthene from the Roots of Acronychia pubescens.
AID1450028Growth inhibition of HEK293 cells2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
AID449704NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID683590Growth inhibition of human BT474 cells at 20 uM incubated for 72 hrs by resazurin dye reduction assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Albopunctatone, an antiplasmodial anthrone-anthraquinone from the Australian ascidian Didemnum albopunctatum.
AID1500910Inhibition of recombinant human N-terminal His6-MBP-tagged PSA expressed in Escherichia coli BL21 STAR (DE3) using 4-Ala-MNA as substrate measured for 30 mins by thefluorescence assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID1574647Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay2019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
AID1423592Antibacterial activity against Micrococcus luteus NRRL B-287 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID542464Antiviral activity against Human poliovirus type 1 infected in Human HeLa cell assessed as inhibition of translation at 10 ug/ml by luciferase reporter gene assay2008Antimicrobial agents and chemotherapy, Jun, Volume: 52, Issue:6
A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.
AID1175720Antigametocytocidal activity against Plasmodium falciparum NF54-pfs16-GPF early (1 to 3) gametocyte assessed as viability after 72 hrs by MitoTracker Red CM-H2XRos/micro-plate confocal imaging system2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID1504887Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 at 5 uM after 72 hrs by DAPI staining based confocal microplate imaging method relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID1639285Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye-based fluorescence assay2019Journal of natural products, 04-26, Volume: 82, Issue:4
Acrotrione: An Oxidized Xanthene from the Roots of Acronychia pubescens.
AID1500912Inhibition of recombinant human C-terminal His10-tagged APN (Lys69 to Lys967 residues) using Ala-AMC as substrate measured for 30 mins by fluorescence assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID1181621Trypanocidal activity against Trypanosoma brucei brucei after 72 hrs by hemocytometry relative to control2014Journal of medicinal chemistry, Aug-14, Volume: 57, Issue:15
Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
AID562803Antimicrobial activity against wild-type Mycoplasma gallisepticum at 1 to 3 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID308325Inhibition of Streptococcus pneumoniae 159 MurM at 1 mM2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Adenosine phosphonate inhibitors of lipid II: alanyl tRNA ligase MurM from Streptococcus pneumoniae.
AID157093Kinetic constant was evaluated by using peptidyl transferase assay against Rat liver ribosome system1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID319343Resistant ratio, IC50 for multidrug resistant human KB3-1 cells to IC50 for human KB3-1 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID1264921Inhibition of Escherichia coli aminopeptidase-N using Leu-pNA as substrate after 30 mins2015European journal of medicinal chemistry, Dec-01, Volume: 106Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
AID1504883Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs by DAPI staining based confocal microplate imaging method2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID319345Growth inhibition of doxorubicin resistant human HepG2 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID1423594Antimycobacterial activity against Mycobacterium aurum ATCC 23366 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID681132TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID1699653Selectivity index, ratio of IC50 for cytotoxicity against human HEK293 cells to IC50 for antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 ring stage2020Journal of natural products, 11-25, Volume: 83, Issue:11
Antiplasmodial Alkaloids from the Australian Bryozoan
AID624628Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID1437497Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human RBC after 72 hrs by DAPI staining based confocal microscopic method
AID688537Cytotoxicity against mouse J774A1 cells by trypan blue exclusion assay2012Journal of natural products, Sep-28, Volume: 75, Issue:9
Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.
AID1241208Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID152702Cytotoxicity against P388 mouse leukemia cells1992Journal of medicinal chemistry, Oct-30, Volume: 35, Issue:22
Synthesis and biological evaluation of 5'-sulfamoylated purinyl carbocyclic nucleosides.
AID680282TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Puromycin: 20 uM) in MDR1-expressing NIH-3T3 cells2004Biochemical and biophysical research communications, Mar-19, Volume: 315, Issue:4
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
AID1404382Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 72 hrs by CellTiter-Glo reagent based luminescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.
AID1264922Inhibition of porcine aminopeptidase-N using Leu-pNA as substrate after 30 mins2015European journal of medicinal chemistry, Dec-01, Volume: 106Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
AID1401091Cytotoxicity against human HepG2 cells after 96 hrs by CCK8 assay2017European journal of medicinal chemistry, Dec-01, Volume: 141African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.
AID1450026Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 measured after 72 hrs by DAPI staining based high throughput screening assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
AID1241210Binding affinity to 5'-FAM-pre-miR-17 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID449705NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID1500913Toxicity in human HeLa cells expressing pCFE-GFP assessed as inhibition of GFP proetin synthesis at 25 uM incubated for 30 mins measured for 2 hrs by spectrophotometric method relative to control2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID1574646Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by DAPI staining-based confocal imaging analysis2019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
AID99173Cross resistance profile versus L1210/R71 cells.1990Journal of medicinal chemistry, Jul, Volume: 33, Issue:7
Structure-activity relationships of antineoplastic agents in multidrug resistance.
AID1500917Antiproliferative activity against human MOLT4 cells after 72 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
AID1274585Cytotoxicity against HEK293 cells assessed as cell viability after 72 hrs by resazurin-based plate reader analysis2015Journal of natural products, Dec-24, Volume: 78, Issue:12
Rotenoids, Flavonoids, and Chalcones from the Root Bark of Millettia usaramensis.
AID1297652Cytotoxicity against HEK293 cells assessed as growth inhibition after 72 hrs by alamar blue viability assay2016European journal of medicinal chemistry, Jun-30, Volume: 116An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics.
AID681130TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID1404380Antiparasitic activity against Cryptosporidium parvum BGF infected in human HCT8 cells incubated for 48 hrs by FITC/DAPI staining based fluorescence assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.
AID1241205Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1639290Selectivity ratio of IC50 for Plasmodium falciparum Dd2 ring stage forms to IC50 for Plasmodium falciparum 3D7 ring stage forms2019Journal of natural products, 04-26, Volume: 82, Issue:4
Acrotrione: An Oxidized Xanthene from the Roots of Acronychia pubescens.
AID102838Compound was evaluated for the cytotoxicity by using P-388 in vitro assay against P-388 mouse lymphoid leukemia cells in 4 mL of Fischer's medium with 10% horse serum.1986Journal of medicinal chemistry, Nov, Volume: 29, Issue:11
Carbocyclic puromycin: synthesis and inhibition of protein biosynthesis.
AID319344Growth inhibition of human HepG2 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells.
AID624629Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay2001The Journal of pharmacology and experimental therapeutics, Nov, Volume: 299, Issue:2
Rational use of in vitro P-glycoprotein assays in drug discovery.
AID562805Antimicrobial activity against wild-type Mycoplasma capricolum at 1 to 3 ug/ml2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
New selectable marker for manipulating the simple genomes of Mycoplasma species.
AID489459Antitrypanosomal activity against Trypanosoma brucei brucei2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
7',8'-Dihydroobolactone, a typanocidal alpha-pyrone from the rainforest tree Cryptocarya obovata.
AID514834Binding affinity to Escherichia coli 23S rRNA H69 assessed as increase in classical-state occupancy by tRNA by crystallography2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1423601Antifungal activity against Saccharomyces cerevisiae ATCC 204508 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID1648003Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as reduction in parasite rowth incubated for 72 hrs by DAPI staining based fluorescence assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
A Meroisoprenoid, Heptenolides, and
AID1648004Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 assessed as reduction in parasite growth incubated for 72 hrs by DAPI staining based fluorescence assay2020Journal of natural products, 02-28, Volume: 83, Issue:2
A Meroisoprenoid, Heptenolides, and
AID1423591Antibacterial activity against Staphylococcus aureus ATCC 6538 after 16 to 48 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
Puromycins B-E, Naturally Occurring Amino-Nucleosides Produced by the Himalayan Isolate Streptomyces sp. PU-14G.
AID1504888Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 at 5 uM after 72 hrs by DAPI staining based confocal microplate imaging method relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID1648008Selectivity ratio of IC50 for HEK293 cells to IC50 for antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd22020Journal of natural products, 02-28, Volume: 83, Issue:2
A Meroisoprenoid, Heptenolides, and
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID602156Novartis GNF Liver Stage Dataset: Malariabox Annotation2011Science (New York, N.Y.), Dec-09, Volume: 334, Issue:6061
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5,649)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904491 (79.50)18.7374
1990's449 (7.95)18.2507
2000's371 (6.57)29.6817
2010's268 (4.74)24.3611
2020's70 (1.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.51 (24.57)
Research Supply Index8.67 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index107.34 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (59.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.02%)5.53%
Reviews140 (2.40%)6.00%
Case Studies3 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other5,684 (97.53%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]